[Apheresis therapy for the treatment of pemphigus and auto-immune blistering disease].
Mayuzumi
Nobuyasu
N
Department of Dermatology, Juntendo University, School of Medicine.
Ikeda
Shigaku
S
Ogawa
Hideoki
H
D001327:Autoimmune Diseases / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D001768:Blister / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D010392:Pemphigus / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D010956:Plasmapheresis / Q000009:adverse effects / Q000379:methods* / Q000592:standards; D011239:Prednisolone / Q000008:administration & dosage; D011379:Prognosis
D007166:Immunosuppressive Agents; D011239:Prednisolone